You are here: All Products  > HutchMed's Surufatinib Approved for 2nd Neuroendocrine Tumor Indication

HutchMed's Surufatinib Approved for 2nd Neuroendocrine Tumor Indication

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products